Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli

J Antimicrob Chemother. 1986 Nov;18(5):557-63. doi: 10.1093/jac/18.5.557.

Abstract

The effects of polymyxin B and polymyxin B nonapeptide (PMBN) on the permeability of the Escherichia coli cytoplasmic membrane were investigated. Both compounds caused loss of free amino acids, uracil and K+ from E. coli. The rates of loss promoted by polymyxin B were one and a half to two-fold greater than those caused by PMBN. Although PMBN mediated loss of low molecular weight substances from E. coli, it was not bactericidal. In contrast, polymyxin B treated E. coli lysed and rapidly lost viability. We suggest that the bactericidal activity of polymyxin B may be related to its previously reported ability to release cytoplasmic proteins from bacteria.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / metabolism
  • Cell Membrane / drug effects
  • Cell Membrane Permeability / drug effects*
  • Escherichia coli / drug effects*
  • Escherichia coli / metabolism
  • Polymyxin B / analogs & derivatives
  • Polymyxin B / pharmacology*
  • Polymyxins / pharmacology*
  • Potassium / metabolism
  • Uracil / metabolism

Substances

  • Amino Acids
  • Polymyxins
  • Uracil
  • polymyxin B nonapeptide
  • Polymyxin B
  • Potassium